Lupus update: perspective and clinical pearls.
Level V
Where this comes from
- Record sourced from PubMed, PMID 19188480.
- Also identified by DOI 10.3949/ccjm.76a.gr005.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Patients with systemic lupus erythematosus (SLE, lupus) have a markedly better survival rate today than they did 50 years ago, but they face a greater risk of cancer, cardiovascular disease, and osteoporosis at early ages. With better understanding of the immunological mechanisms of the disease, new avenues of therapy are emerging.